Patents by Inventor Colin Stephens

Colin Stephens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250146087
    Abstract: The present invention relates to prostate cancer (PC), in particular the identification of certain bacteria in prostate cancer tissues or liquid biopsies and the use of such identification as a prognostic indicator of cancer progression. The present invention also relates to cultures of newly identified bacteria and means for identifying such bacteria in biological samples.
    Type: Application
    Filed: January 18, 2023
    Publication date: May 8, 2025
    Inventors: Colin Stephen Cooper, Daniel Simon Brewer, Rachel Hurst, Abraham Farag Salah Gihawi, Justin Joseph O'Grady, John Richard Wain, Emma Jane Meader, Ghanasyam Rallapalli
  • Patent number: 12290561
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Grant
    Filed: October 24, 2023
    Date of Patent: May 6, 2025
    Assignees: Virion Therapeutics, LLC, The Wistar Institute
    Inventors: Hildegund C J Ertl, Colin Stephen Magowan
  • Publication number: 20240091347
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Application
    Filed: October 24, 2023
    Publication date: March 21, 2024
    Inventors: Hildegund CJ ERTL, Colin Stephen MAGOWAN
  • Patent number: 11850282
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: December 26, 2023
    Assignees: Virion Therapeutics, LLC, The Wistar Institute
    Inventors: Hildegund C J Ertl, Colin Stephen Magowan
  • Publication number: 20230349000
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Application
    Filed: July 5, 2023
    Publication date: November 2, 2023
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper
  • Patent number: 11746380
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: September 5, 2023
    Assignee: UNIVERSITY OF EAST ANGLIA
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper
  • Publication number: 20230063089
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Application
    Filed: January 8, 2021
    Publication date: March 2, 2023
    Inventors: Hildegund CJ ERTL, Colin Stephen MAGOWAN
  • Patent number: 11544444
    Abstract: Disclosed is a method of phonetically encoding a text document. The method comprises providing, for a current word in the text document, a phonetically equivalent encoded word comprising one or more syllables, each syllable comprising a sequence of phonemes from a predetermined phoneme set, the sequence being phonetically equivalent to the corresponding syllable in the current word, and adding the phonetically equivalent encoded word or the current word at a current position in the phonetically encoded document, Each phoneme in the phoneme set is associated with a base grapheme that is pronounced as the phoneme in one or more English words.
    Type: Grant
    Filed: December 31, 2019
    Date of Patent: January 3, 2023
    Assignee: Readable English, LLC
    Inventors: Christopher Colin Stephen, Ann Elizabeth Fitts
  • Publication number: 20220175913
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 9, 2022
    Inventors: Hildegund CJ ERTL, Colin Stephen MAGOWAN
  • Patent number: 11291716
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 5, 2022
    Assignees: Virion Therapeutics, LLC, The Wistar Institute
    Inventors: Hildegund C J Ertl, Colin Stephen Magowan
  • Publication number: 20220093251
    Abstract: The present invention relates to biomarkers and diagnostic profiles based on the expression status of particular genes for use in the diagnosis of prostate cancer, in particular the early detection of prostate cancer and prediction of disease progression and Gleason ?4 cancer. The present invention also provides methods of diagnosis and treatment of prostate cancer, and kits for the early detection of prostate cancer based on the expression status of the biomarkers in biological samples, in particular urine samples.
    Type: Application
    Filed: January 28, 2020
    Publication date: March 24, 2022
    Inventors: Colin Stephen Cooper, Jeremy Paul Clark, Daniel Simon Brewer, Shea Peter Connell, Helen Marie Curley
  • Publication number: 20210393770
    Abstract: Provided herein are non-naturally occurring variants of the hepatitis B virus (HBV) Core protein, the HBV polymerase N-terminal domain, and the HBV polymerase C-terminal domain, as well as immunogenic fragments thereof. Fusion proteins comprising the HBV variants fused to a herpes simplex virus (HSV) glycoprotein (gD) sequence, as well as methods of using the fusion proteins, are also provided.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Inventors: Hildegund CJ ERTL, Colin Stephen MAGOWAN
  • Publication number: 20200285812
    Abstract: Disclosed is a method of phonetically encoding a text document. The method comprises providing, for a current word in the text document, a phonetically equivalent encoded word comprising one or more syllables, each syllable comprising a sequence of phonemes from a predetermined phoneme set, the sequence being phonetically equivalent to the corresponding syllable in the current word, and adding the phonetically equivalent encoded word or the current word at a current position in the phonetically encoded document, Each phoneme in the phoneme set is associated with a base grapheme that is pronounced as the phoneme in one or more English words.
    Type: Application
    Filed: December 31, 2019
    Publication date: September 10, 2020
    Inventors: Christopher Colin Stephen, Ann Elizabeth Fitts
  • Publication number: 20200263255
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Application
    Filed: October 5, 2017
    Publication date: August 20, 2020
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper
  • Patent number: 10521511
    Abstract: Disclosed is a method of phonetically encoding a text document. The method comprises providing, for a current word in the text document, a phonetically equivalent encoded word comprising one or more syllables, each syllable comprising a sequence of phonemes from a predetermined phoneme set, the sequence being phonetically equivalent to the corresponding syllable in the current word, and adding the phonetically equivalent encoded word or the current word at a current position in the phonetically encoded document. Each phoneme in the phoneme set is associated with a base grapheme that is pronounced as the phoneme in one or more English words.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: December 31, 2019
    Assignee: Accessible Publishing Systems Pty Ltd
    Inventors: Christopher Colin Stephen, Ann Elizabeth Fitts
  • Publication number: 20180349348
    Abstract: Systems, methods, and software can be used to generate predictive text on an electronic device. In some aspects, one computer-implemented method includes receiving, at an input method editor (IME) operating on an electronic device, a text prediction indicator for an editable field outputted by an application; determining, based on the text prediction indicator, whether a text input from the editable field is allowed to be stored; in response to determining that the text input from the editable field is allowed to be stored, storing the text input; determining a predictive text; and outputting the predictive text on the electronic device.
    Type: Application
    Filed: June 5, 2017
    Publication date: December 6, 2018
    Applicant: BlackBerry Limited
    Inventors: Neil Patrick ADAMS, Colin Stephen Samuel HO, Mark Alex CULLUM
  • Publication number: 20170287356
    Abstract: A teaching system for teaching a user, the teaching system comprising a learning interface module (112), a user classification module (116) and a learning activity control module (114, 122), wherein: the learning interface module (112) is arranged to receive user information associated with a user and store the user information in a user information database (115); the user classification module (116) is arranged to obtain a user classification code based on the user information and store the user classification code in a learning outcome database (117), and the learning activity control module (114, 122) is arranged to select at least one learning activity from a learning activity database (118) based on the user classification code and communicate the selected learning activity to the learning interface module (112) for reception by the user.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 5, 2017
    Inventors: Christopher Colin Stephen, Aswad Rehan Akram, Ann Elizabeth Fitts
  • Patent number: 9430555
    Abstract: Systems and methods are disclosed for producing documents in a specialized format adapted to aid readability, such as word-recognition and word-processing capabilities. Marked-up documents stored in a repository are created by marking up previously unmarked-up documents according to one or more schemas, to include explicit structural information that corresponds to implicit structural information originally contained in the unmarked-up documents. A user may request a specially formatted document by selecting one of a number of available stored document formats including formatting rules or parameters to be applied to a selected one of the marked-up documents.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: August 30, 2016
    Assignee: Accessible Publiahing Systems Pty Ltd
    Inventors: Gregory Lyle Duncan, Christopher Colin Stephen
  • Publication number: 20150223906
    Abstract: A medical procedure localization aid produces reference marks on both the patient and the medical imaging scan. The aid is defined by an imaging substrate having indicia on one side that is opaque to medical imaging and a second substrate having indicia that appears on the patient's surface for the procedure. Anchor points align the second substrate to the same position as the first substrate on the patient. By visualizing the location of a target on the scan image relative to the indicia on the scan image and comparing that with indicia on the patient, a medical processional may reliably locate where a medical procedure should be performed.
    Type: Application
    Filed: August 27, 2013
    Publication date: August 13, 2015
    Inventors: Colin Stephen O'Neill, Nicholas Drake Seto
  • Patent number: 9043718
    Abstract: An electronic device for text prediction in a virtual keyboard. The device includes a memory including an input determination module for execution by the microprocessor, the input determination module being configured to: receive signals representing input at the virtual keyboard, the virtual keyboard being divided into a plurality of subregions, the plurality of subregions including at least one subregion being associated with two or more characters and/or symbols of the virtual keyboard; identify a subregion on the virtual keyboard corresponding to the input; determine any character or symbol associated with the identified subregion; and if there is at least one determined character or symbol, provide the at least one determined character or symbol to a text prediction algorithm.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: May 26, 2015
    Assignee: BlackBerry Limited
    Inventors: Colin Stephen Samuel Ho, Douglas Rider